CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis

Overview of attention for article published in Frontiers in immunology, November 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 5 X users

patent: 1 patent

Readers on

mendeley: 14 Mendeley

Summary X Patents

So far, Altmetric has seen 1 patent that references this research output.

AGENT FOR TREATING OR PREVENTING IDIOPATHIC PULMONARY FIBROSIS

Application WO-2023182512-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.